At the molecular level, the active components of KHJ exerted therapeutic effects against acute pharyngitis by modulating the levels of key inflammatory mediators, including COX-2, NF-κB p65, and p-NF-κB p65, via a multi-target mechanism. This evidence concerns the gene PTGS2 and acute pharyngitis.